Biotech Entrepreneurs Offer Tips For Winning an SBIR—Including a Top 10 List of Dos and Don’ts

needed lab equipment, office furniture, and other key assets from biotechs that were shutting down or downsizing their operations. He also says it helps to recruit academic researchers to help on R&D, because the government encourages such industry-academic collaborations, and it looks good on the SBIR grant application.

“What I have to say about SBIRs is that you really have to think hard about how you want to write these applications,” says Finn, who confided that he submitted six SBIR proposals before winning approval. The scientists who reviewed his grant applications just didn’t understand the significance of his approach, which used structure-based drug design to identify and develop new antibiotics. “I don’t want to say you have to write it for someone with a fourth grade education,” Finn says, “but you really have to keep it simple, so they can understand.”

On writing grant applications, Mandala Biosciences’ Larocca adds, “My advice is to be passionate. You have to be able to write your grant in a way to make it sound exciting.”

Scott Struthers, the founder and chief scientific officer of Crinetics Pharmaceuticals, offered a Top 10 list of things you need to know to win a SBIR grant.

First, Struthers says, are the “Top 5 things that can hurt you:”

—Submitting a grant application that is single-spaced and has no margins, making the text so dense that no reviewer wants to read it.

—Proposing a chemistry grant without including structural diagrams of the compounds because you’re worried someone might appropriate the idea.

—Characterizing your proposal as “fantastic,” “outstanding,” etc.

—Telling your primary reviewer that he or she is ignorant, uneducated, etc.

—Including a lot of B.S., because it’s easy to smell. “If you waste their time,” Struthers says, “they’re going to waste your grant.”

And the five things that can help you:

—Thinking very carefully about your outline. Be sure it flows logically from one topic to another.

—Including a small table that includes definitions of scientific terms near the beginning of the grant. Reviewers are rarely experts in the same field.

—Extracting key messages from the application in an inset box. It’s worth the space.

—Including a clear schematic to explain a scientific concept, or organizational chart to explain a collaboration.

—Checking spelling and grammatical errors, and making sure the citations are correct.

[Editor’s note: A workshop on the ABCs of Small Business Loans is set for Tuesday May 25. Details are here]

Author: Bruce V. Bigelow

In Memoriam: Our dear friend Bruce V. Bigelow passed away on June 29, 2018. He was the editor of Xconomy San Diego from 2008 to 2018. Read more about his life and work here. Bruce Bigelow joined Xconomy from the business desk of the San Diego Union-Tribune. He was a member of the team of reporters who were awarded the 2006 Pulitzer Prize in National Reporting for uncovering bribes paid to San Diego Republican Rep. Randy “Duke” Cunningham in exchange for special legislation earmarks. He also shared a 2006 award for enterprise reporting from the Society of Business Editors and Writers for “In Harm’s Way,” an article about the extraordinary casualty rate among employees working in Iraq for San Diego’s Titan Corp. He has written extensively about the 2002 corporate accounting scandal at software goliath Peregrine Systems. He also was a Gerald Loeb Award finalist and National Headline Award winner for “The Toymaker,” a 14-part chronicle of a San Diego start-up company. He takes special satisfaction, though, that the series was included in the library for nonfiction narrative journalism at the Nieman Foundation for Journalism at Harvard University. Bigelow graduated from U.C. Berkeley in 1977 with a degree in English Literature and from the Columbia University Graduate School of Journalism in 1979. Before joining the Union-Tribune in 1990, he worked for the Associated Press in Los Angeles and The Kansas City Times.